IHC results also validated that linc00958 downregulation could inhibit the tumor microvessel density marker CD34 and VEGFA in tumors, supporting that the knockdown of linc00958 inhibited the angiogenesis in xenograft model (Fig. 5H-I). The gene discussed is VEGFA; the disease is neoplasm.